Work

rViscumin, a novel anticancer agent — preclinical and clinical development status

Year: 2001

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(01)80333-6

Authors: K. Wilhelm-Ogunbiyi, B. Möckel, A. Burger, M. Langer, H. Zinke, H.H. Fiebig, H. Lentzen

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1963497319

FWCI:

Cites:

Cited by: 2

Related to: 10